Glycos Biotechnologies Produces Biochemicals In Pilot Plant Size Environment
Published: 10-Mar-2010
Glycos Biotechnologies, an emerging specialty chemicals company, said that it has produced lactic acid and advanced ethanol in a commercial size facility capable of producing up to 150,000 liters of chemicals.
GlycosBio has created a platform that can consume carbon from multiple non-sugar feedstock sources to produce a variety of chemical products. The approach not only eliminates the risk of a sugar-only based feedstock strategy but also provides product flexibility and a larger addressable market opportunity for producers.
Rich Cilento, CEO of Glycos Biotechnologies, said: “Replicating what has been accomplished in our lab now in a commercial setting, and at a larger scale, is a significant achievement for GlycosBio. Our work in the pilot plant will help the organization meet partner milestones related to the commercialization efforts we already have underway. In addition, the success of the pilot production validates the efficiency and ease-of-scale of GlycosBio’s technology in larger production systems and proves our economic models and the profit opportunities we can offer producers of chemicals and biofuels. With the pilot plant successfully operational we are now focused on engaging the marketplace to secure additional commercialization partnerships around the world.”
Paul Campbell, chief scientific officer of Glycos Biotechnologies, said: “By using our proprietary microbes and bioprocess technologies as an alternative to conventional petrochemical-based manufacturing processes, GlycosBio has invented a sustainable and cost-efficient approach to the production of next generation bio-products. Through the creation of biologically ‘balanced’ pathways inside the microbe we have been able to uniquely develop microorganisms that naturally produce the desired end-products.”
GlycosBio is focused on the production of specialty chemicals that can be used as building blocks for a wide range of applications including biodegradable and non-degradable plastics. In addition, other applications for GlycosBio’s chemicals include surfactants and fuels such as advanced ethanol. By bridging innovative metabolic engineering and efficient process design, GlycosBio discoveries will drive sustainable solutions for the world’s energy, chemicals, and materials problems.
Network Sites

Suppliers To This Sector
Browse A-Z
Almac
Drug Development Solutions ...
Boehringer Ingelheim
Drug Substance and Drug Product Services ...
Cerbios-Pharma SA
High Quality & Reliable Services ...
CurTec
Producer & Manufacturer of Plastics Packaging ...
Cutting Edge Information
Pharmaceutical Business Intelligence Reports ...
IRIS Biotech
Peptide Synthesis and Pharmaceutical Intermediates ...
White Papers
Browse A-Z
CaseBase Management
BaseCon was established in 1999 to support the pharmaceutical sector with innovative IT so ...
SafetyBase Interchange
BaseCon was established in 1999 to support the pharmaceutical sector with innovative IT so ...
ClinicalBase Trial
BaseCon was established in 1999 to support the pharmaceutical sector with innovative IT so ...
Reliable Prediction of White Plasma Levels
Our kinetics & metabolism experts can help you select and further develop your candidate d ...
Kinetics and Metabolism
Our kinetics & metabolism experts can help you select and further develop your candidate d ...
Drug Safety Evaluation
Our kinetics & metabolism experts can help you select and further develop your candidate d ...


Delicious
Digg
LinkedIn
Reddit
Stumble
Viadeo
Mail sent successfully